Picture [LSE] – The Business Web Portal 650x65px
Organisation › Details

Nuclea Biotechnologies Inc.

Nuclea Biotechnologies, Inc. is headquartered in Pittsfield, Massachusetts with additional operations in Worcester and Cambridge, Massachusetts. Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung, and prostate cancer, as well as for diabetes and other metabolic syndromes. Nuclea also performs research leading to novel molecular oncology companion diagnostics for the pharmaceutical and biotechnology industries. *


Period Start 2005-04-01 established
Period End 2016-08-30 bankruptcy filed
Products Industry diagnostics (medical/biological)
  Industry 2 mass spectrometry (MS)
Persons Person Muraca, Patrick J. (Nuclea Biotechnologies 201309 CEO)
  Person 2 Lopez, Mary F. (Nuclea Biotechnologies 201502– COO before Thermo Fisher BRIMS + PerkinElmer + Proteome Systems)
  Street 105 South Street
  City 01201 Pittsfield, MA
  Tel +1-413-749-4705
    Address record changed: 2018-07-24
Basic data Employees n. a.
    * Document for �About Section�: Nuclea Biotechnologies, Inc.. (2/19/15). "Press Release: Prominent Proteomics Business Development Team Joins Nuclea. Commercialization and Proteomics Expert Dr. Mary Lopez Will Be Appointed COO". Pittsfield, MA.
Record changed: 2018-10-31


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Nuclea Biotechnologies Inc.

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [LSE] – The Business Web Portal 650x65px

» top